Kerala ayurveda Limited has issued a clarification to BSE Limited regarding significant movement in its equity share price, responding to an inquiry dated April 8, 2026. The company's Chief Financial Officer George K T addressed the exchange's concerns through an official communication confirming regulatory compliance and transparency in disclosures.

Regulatory Compliance Confirmation

The company has affirmed its adherence to disclosure obligations under SEBI regulations. Kerala Ayurveda Limited confirmed that it has been making timely disclosures of all events and information that could impact company operations or performance, including price-sensitive information, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management's Position on Price Movement

The company's management has clarified its stance on the recent share price volatility through key statements:

Ongoing Disclosure Commitments

Kerala Ayurveda Limited has reiterated its commitment to maintaining transparency with stock exchanges. The company stated it will continue making disclosures as and when any event or information requiring disclosure under Regulation 30 arises. This commitment ensures investors receive timely information about material developments that could impact their investment decisions.

Corporate Structure Details

The communication was signed by George K T, Chief Financial Officer and Designated Officer for filing, representing the company's senior management. Kerala Ayurveda Limited operates as an ISO 9001:2015 certified company with its registered office in Ernakulam, Kerala, and corporate office in Bengaluru. The company holds CIN L24233KL1992PLC006592 and trades under BSE Scrip Code 530163.

Kerala Ayurveda Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate pertains to the quarter ended March 31, 2026, and was filed on April 2, 2026.

Regulatory Compliance Details

The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, by Integrated Registry Management Services Private Ltd., which serves as the company's Registrar and Share Transfer Agent. This quarterly filing is a mandatory requirement for listed companies to ensure transparency in their dematerialization processes.

Certificate Confirmation

Integrated Registry Management Services Private Ltd. confirmed that all securities received from Depository Participants for dematerialization during the quarter were properly processed. The registrar verified that:

• Securities received for dematerialization were confirmed to depositories and stock exchanges
• All security certificates were mutilated and cancelled after verification
• Depository names were substituted in the register of members as registered owners within the stipulated 15-day period

Corporate Information

The filing was digitally signed by George K T, Chief Financial Officer and Designated Officer for filing, on April 6, 2026. Kerala Ayurveda Limited operates as an ISO 9001:2015 certified company with its registered office in Ernakulam, Kerala, and corporate office in Bengaluru.

This compliance filing demonstrates the company's adherence to regulatory requirements and maintains transparency in its share transfer and dematerialization processes for stakeholders.